Lukka HR, Deshmukh S, Bruner DW, Bahary JP, et al. Five-year patient reported outcomes in NRG Oncology RTOG 0938, evaluating two ultrahypofractionated regimens for prostate cancer. Int J Radiat Oncol Biol Phys 2022 Dec 30:S0360-3016(22)03671.
PMID: 36592721